{"subsection_name": null, "pub_date": "2011-10-04T09:51:25Z", "byline": {"original": "By ANDREW POLLACK", "person": [{"lastname": "POLLACK", "organization": "", "rank": 1, "role": "reported", "firstname": "Andrew"}]}, "abstract": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "word_count": 970, "print_page": null, "news_desk": null, "snippet": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "value": "Eyes and Eyesight", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "3"}, {"name": "subject", "value": "Avastin (Drug)", "rank": "2"}, {"name": "subject", "value": "Macular Degeneration", "rank": "5"}, {"name": "type_of_material", "value": "News", "rank": "1"}, {"name": "subject", "value": "Medicare", "rank": "6"}, {"name": "organizations", "value": "Genentech Inc", "rank": "7"}, {"name": "organizations", "value": "Veterans Affairs Department", "rank": "8"}, {"name": "unknown", "value": "Lucentis", "rank": "9"}], "type_of_material": "Blog", "lead_paragraph": "Dr. Robert Feig, a retina specialist in Brooklyn and the Bronx, says he wants to save patients and Medicare money by treating eye diseases with a drug that costs $50 a dose, rather than one that costs $2,000 a dose.", "web_url": "http://prescriptions.blogs.nytimes.com/2011/10/04/doctors-grow-wary-of-avastin-for-eye-treatment/", "section_name": "Health", "headline": {"main": "Doctors Grow Wary of Avastin for Eye Treatment", "kicker": "Prescriptions"}, "slideshow_credits": null, "_id": "4fd3a1e58eb7c8105d8e92dc", "document_type": "blogpost"}